Home › Funds › Lion Point Capital, LP › PRAX
Lion Point Capital, LP position in PRAX
PRAXIS PRECISION MEDICINES I · Health Care
Lion Point Capital, LP reported holding 4,450 shares of PRAX (PRAXIS PRECISION MEDICINES I) in its Q2 2026 13F filing — a position valued at US$1.5M, representing 7.13% of its reported portfolio and ranking #2 among its reported holdings. Lion Point Capital, LP has disclosed PRAX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Lion Point Capital, LP's PRAX position evolved
Lion Point Capital, LP first disclosed a stake in PRAX in Q3 2025 at 5,700 shares (US$302K). The position peaked in Q2 2026 at 4,450 shares, worth US$1.5M. Across 4 filings, Lion Point Capital, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 4,450 shares valued at US$1.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 5.70K | $302.10K | New |
| Q4 2025 | 4.45K | $1.31M | Reduce |
| Q1 2026 | 4.45K | $1.43M | Hold |
| Q2 2026 | 4.45K | $1.49M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PRAX and 13F data
PRAX (PRAXIS PRECISION MEDICINES I) is a Health Care company. 74 other funds we track also report a position in PRAX — the largest reported positions include Jupiter Topco LLC (US$1.15B), Janus Henderson Group (US$1.11B), PERCEPTIVE ADVISORS LLC (US$681.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PRAX
- Jupiter Topco LLC 3.42M sh · $1.15B · Q2 2026
- Janus Henderson Group 3.46M sh · $1.11B · Q1 2026
- PERCEPTIVE ADVISORS LLC 2.04M sh · $681.63M · Q2 2026
- BAKER BROS. ADVISORS LP 1.75M sh · $586.95M · Q2 2026
- Orbis Allan Gray Ltd 1.53M sh · $512.16M · Q2 2026
- ADAGE CAPITAL PARTNERS GP, L.L.C. 1.02M sh · $339.97M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 963.35K sh · $322.52M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 959.05K sh · $321.08M · Q2 2026
- Cormorant Asset Management, LP 640.00K sh · $214.27M · Q2 2026
- Hood River Capital Management LLC 425.17K sh · $142.34M · Q2 2026
- Vivo Capital, LLC 271.12K sh · $90.77M · Q2 2026
- Logos Global Management LP 260.00K sh · $87.05M · Q2 2026
More on Lion Point Capital, LP
FAQ
How long has Lion Point Capital, LP held PRAX?
Lion Point Capital, LP has disclosed PRAX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Lion Point Capital, LP's current position in PRAX?
As of Q2 2026, Lion Point Capital, LP holds 4.45K shares of PRAX (PRAXIS PRECISION MEDICINES I), valued at $1.49M, representing 7.13% of its reported portfolio and ranking #2.
Has Lion Point Capital, LP been buying or selling PRAX?
In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in PRAX. The position peaked in Q2 2026 at 4.45K shares.
Which other funds hold PRAX?
Other major institutional holders of PRAX include Jupiter Topco LLC, Janus Henderson Group, PERCEPTIVE ADVISORS LLC, among 74 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.